tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

PharmX Technologies Issues 7.27 Million Performance Rights

Story Highlights
PharmX Technologies Issues 7.27 Million Performance Rights

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Corum Group Limited ( (AU:PHX) ) has provided an announcement.

PharmX Technologies Limited has announced the issuance of 7,270,000 performance rights under an employee incentive scheme. These securities are unquoted and subject to transfer restrictions until the restriction period ends, reflecting the company’s strategy to incentivize its workforce and align their interests with long-term corporate goals.

More about Corum Group Limited

PharmX Technologies Limited operates in the technology sector, focusing on developing innovative solutions for the pharmaceutical industry. The company is involved in creating technology-driven products and services that aim to enhance the efficiency and effectiveness of pharmaceutical operations.

Average Trading Volume: 862,161

Technical Sentiment Signal: Buy

Current Market Cap: A$77.81M

Learn more about PHX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1